This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated COL11A1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-COL11A1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~181.1 kDa | |
| Gel | 8–10% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | Processing-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 4 isoform(s) |
The M02909 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | K562 cell lysate (catalog M02909) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M02909; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
COL11A1 has a predicted 181.1 kDa full-length mass; processing, glycosylation, isoforms, and chain association may affect migration, but no empirical band is supplied.
| Band near 181.1 kDa | compatible with the predicted full-length precursor; identity requires confirmation |
| Band below 181.1 kDa | may reflect signal-peptide or propeptide cleavage |
| Little or no band in whole-cell lysate | COL11A1 is secreted into the extracellular matrix |
| Several bands at different positions | may reflect processing or isoforms A, B, C, and 4; their migration is unestablished |
| Higher-mass band under nonreducing conditions | may reflect disulfide-linked chain association |
| UniProt full-length precursor mass | predicts 181.1 kDa before processing |
| Signal peptide at residues 1–35 | cleavage can lower mature-chain mass |
| Propeptide at residues 36–511 | cleavage can lower mature-chain mass |
| N-linked glycosylation at Asn1640 | may alter apparent migration; a visible shift is unestablished |
| Interchain disulfide at residue 1630 | may retain a higher-mass chain complex under nonreducing conditions |
| Isoforms A, B, C, and 4 | may differ in size, but distinct band positions are unestablished |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | COL11A1 is secreted into the extracellular matrix | examine extracellular matrix material and include a positive control |
| Band higher than expected | disulfide-linked chain association may persist | compare reducing and nonreducing samples |
| Band lower than expected | signal-peptide or propeptide cleavage may occur | check whether the antibody recognizes the retained region and compare a positive control |
| Multiple bands | processing or isoforms A, B, C, and 4 may contribute | compare a positive control and confirm bands with an independent antibody |
| Weak or no signal | limited COL11A1 in the sampled material may reduce signal | check extracellular matrix material and verify the antibody with a positive control |
| Fragments below expected size | propeptide cleavage or additional fragmentation may produce smaller species | check antibody epitope location and compare freshly prepared samples |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for COL11A1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
M02909 is a rabbit monoclonal anti-COL11A1 antibody listed as reactive with human samples. Its Western blot image shows COL11A1 expression in K562 cell lysate; the supplied evidence does not establish performance in other sample types.
Which to pick: M02909 is the only listed option. It has a Western blot image from K562 cell lysate and is listed for human reactivity; assess suitability for other specimens separately.